---
category: news
title: "Hepion Pharmaceuticals Announces Initiation of Dosing in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial"
excerpt: "Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”),"
publishedDateTime: 2022-09-12T12:03:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/technology-health-covid-clinical-trials-d579b7a19ef521b4b3feda405fd1746d"
webUrl: "https://apnews.com/press-release/globe-newswire/technology-health-covid-clinical-trials-d579b7a19ef521b4b3feda405fd1746d"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "vRVJMkdWe34ewnueKYa0Lp9OWow0XHqhCZGIYbEQHEMMozxnUqQehYA/uYrnau0WbmKtQruw+eC2j1WhfZE0QfmaNwhQqhJwewC0p7lP9ElLRf0l1YMGweQzckB7zRDictXACM8l3rtCh1lU90JL4hLl9lu4scvIEP7u2zP2BDK1bUQqoJfc+bZpweODQfKpdhsiAvz17LvcnpiASLb7stf1+6fICjbf7qEDhuNFYzoCwnvo7H8hpY8vsWZkW5b9EMvn8GHRSQYecJoINVzNPS89qKVAa4NYaX9CclNQnyE+4A9pVwva5DE0PaJ0MiWkBXlBI0Im0H4/o7p9ku6m2DNL/LvMLn8oIq+4WSYGKZk=;poYoaKybrtCu/iAEkERulQ=="
---

